BlackRock, Inc. 13D and 13G filings for Talaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-09 4:02 pm Sale |
2022-07-31 | 13G | Talaris Therapeutics, Inc. TALS |
BLACKROCK INC BLK |
198,430 4.800% |
-41,116 (-17.16%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Talaris Therapeutics, Inc. TALS |
BLACKROCK INC BLK |
239,547 5.800% |
239,547 (New Position) |
Filing |